| DVAX Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the DVAX market cap history going back to 11/10/2014:
Also see: DVAX Shares Outstanding History and DVAX YTD Return |
DVAX Market Cap History — Dynavax Technologies Capitalization Over Time
As of 11/3/2025 Dynavax Technologies has a market cap of 1.20 billion. Investors often follow the DVAX market cap history to compare the size of the company over time.
This page shows DVAX market capitalization trends over time, with 43 market cap datapoints presented, dating back to 11/10/2014.
| DVAX Market Cap History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
DVAX Historical Market Cap: +9.99% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| DVAX Stock Price Chart |
| About Dynavax Technologies Corp |
| Dynavax Technologies Corporation is a commercial-stage biopharmaceutical company, which is engaged in developing and commercializing vaccines. Co.'s products include HEPLISAV-B hepatitis B vaccine and CpG 1018. Its HEPLISAV-B ((Recombinant)(Adjuvanted) is indicated for the prevention of infection caused by all known subtypes of the hepatitis B virus in adults 18 years of age and older. HEPLISAV-B is a two-dose hepatitis B vaccine for adults. It also manufactures and sells CpG 1018 adjuvant, the adjuvant used in HEPLISAV-B. It is also engaged in developing a multi-program clinical pipeline leveraging CpG 1018 adjuvant to develop improved vaccines for indications with unmet medical needs. We show 43 historical shares outstanding datapoints in our DVAX shares outstanding history coverage, used to compute DVAX market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing DVAX market cap history over the course of time is important for investors interested in comparing DVAX's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of DVAX versus a peer is one thing; comparing DVAX market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like DVAX can fluctuate over the course of history. With this page we aim to empower investors researching DVAX by allowing them to research the DVAX market cap history. |
| DVAX Current Stock Quote |
Quotes delayed 20 minutes  Free DVAX Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: The Importance of Market Cap | |
|
Video: The Importance of Market Cap
| DVAX Share Performance |
| Market Cap Peers |
| Dynavax Technologies (DVAX) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
DVCR Market Cap History DWTX Market Cap History DXCM Market Cap History DYAI Market Cap History DYN Market Cap History DYNT Market Cap History EAR Market Cap History EBS Market Cap History ECOR Market Cap History ECYT Market Cap History More Healthcare companies » |
DVAX Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
